Cargando…
Intravenous Tissue Plasminogen Activator in Combination With Mechanical Thrombectomy: Clot Migration, Intracranial Bleeding, and the Impact of “Drip and Ship” on Effectiveness and Outcomes
Purpose: Intravenous tissue plasminogen activator (tPA) is indicated prior to mechanical thrombectomy (MT) to treat large vessel occlusion (LVO). However, administration takes time, and rates of clot migration complicating successful retrieval and hemorrhagic transformation may be higher. Given time...
Autores principales: | Chang, Adam, Beheshtian, Elham, Llinas, Edward J., Idowu, Oluwatoyin R., Marsh, Elisabeth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794010/ https://www.ncbi.nlm.nih.gov/pubmed/33424741 http://dx.doi.org/10.3389/fneur.2020.585929 |
Ejemplares similares
-
S100b in acute ischemic stroke clots is a biomarker for post-thrombectomy intracranial hemorrhages
por: Rossi, Rosanna, et al.
Publicado: (2023) -
Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients
por: Seners, Pierre, et al.
Publicado: (2019) -
Endovascular treatment for ischemic stroke with the drip-and-ship model—Insights from the German Stroke Registry
por: Schaefer, Jan Hendrik, et al.
Publicado: (2022) -
Drip-and-Ship for Thrombectomy Treatment in Patients With Acute Ischemic Stroke Leads to Inferior Clinical Outcomes in a Stroke Network Covering Vast Rural Areas Compared to Direct Admission to a Comprehensive Stroke Center
por: Taschner, Christian A., et al.
Publicado: (2021) -
Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
por: Marsh, Elisabeth B., et al.
Publicado: (2013)